By lowering the risk of major cardiovascular events by 20% in overweight or obese patients without diabetes, semaglutide stands out as a breakthrough treatment for cardiovascular risk reduction
Common medications in this class include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Just as compounded tirzepatide offers an affordable alternative to brand-name Mounjaro and Zepbound, compounded semaglutide provides the same benefits at a fraction of the cost
To help Frisco patients afford treatment, Dr
However, these medications can cause gastrointestinal side effects such as nausea and vomiting
The mechanism is fundamentally different